Immune Cell Dysfunction, Not Absence, Marks Skin Cancer Risk
Nonmelanoma skin cancer in immunosuppressed patients reflects immune cell dysfunction, not absence — a shift that could reshape surveillance and therapy.
Topic
Immunosuppression
Topic
Immunosuppression
Dysfunction, Not Absence, of Immune Cells Defines Skin Cancer Risk
MD Anderson researchers report that skin cancers in immunosuppressed patients arise from immune cell dysfunction rather than immu…
Discovery May Open New Treatment Paths for Skin Cancer in Immunosuppressed Patients
A newly reported discovery may enable new skin cancer treatments for immunosuppressed patients, a group in whom immunotherapy rem…